Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine
NCT01006070 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2012-03-21
Summary
The purpose of this study is to create a prospective database of patients with myeloma affecting the spine. This database will define changes in health-related quality of life over time, and the effect of incident fractures and their treatment on specific measures of pain, physical function, pulmonary function, and future fractures. In 2008, the UCSF Myeloma Service was actively caring for 347 patients with myeloma, of which 150 patients had lytic lesions on radiographs, and 100 had a known vertebral fracture. This population, as well as any new myeloma patients, will serve as the source of the study population.
Conditions
Interventions
- PROCEDURE
-
kyphoplasty
surgical kyphoplasty
Sponsors & Collaborators
-
Medtronics, Inc.
collaborator INDUSTRY -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Jeffrey Wolf, MD · University of California, San Francisco
-
Sigurd Berven, MD · University of California, San Francisco
-
Thomas Martin, MD · University of California, San Francisco
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2011-03-31
- Completion
- 2011-03-31
Countries
- United States
Study Locations
More Related Trials
-
High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
NCT00002630 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00014508 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis
NCT00002810 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00004903 ·Status: UNKNOWN ·Phase: PHASE2
-
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
NCT01558778 ·Status: WITHDRAWN ·Phase: NA
-
Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer
NCT01407341 ·Status: TERMINATED ·Phase: PHASE1
-
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
NCT01008462 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers
NCT00003163 ·Status: UNKNOWN ·Phase: PHASE2
-
Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT00028600 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
NCT00651937 ·Status: COMPLETED ·Phase: PHASE2
-
SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma
NCT00002548 ·Status: COMPLETED ·Phase: PHASE3
-
The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)
NCT01825161 ·Status: COMPLETED
-
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
NCT00046852 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00005804 ·Status: COMPLETED ·Phase: PHASE2
-
TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma
NCT03506802 ·Status: WITHDRAWN ·Phase: PHASE1
-
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
NCT00002594 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autograft (APA²)
NCT04320420 ·Status: UNKNOWN ·Phase: NA
-
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
NCT00002552 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
NCT00007995 ·Status: COMPLETED ·Phase: PHASE2
-
Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma
NCT00008268 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
NCT00002599 ·Status: UNKNOWN ·Phase: PHASE3
-
Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer
NCT00002553 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
NCT00027547 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
NCT00064337 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic Cell Therapy for Adults With Hematologic Malignancies
NCT00208962 ·Status: COMPLETED ·Phase: PHASE2